Haemonetics Corp (HAE) — 10-Q Filings
All 10-Q filings from Haemonetics Corp. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Haemonetics' Q2 Net Income Rises Amidst Revenue Dip, Strategic Acquisitions
— Nov 6, 2025 Risk: medium
Haemonetics Corporation reported a net income of $38.684 million for the three months ended September 27, 2025, an increase of 14.3% from $33.831 million in the -
Haemonetics Q1 Earnings Soar 25% on Strong Revenue Growth
— Aug 7, 2025 Risk: low
Haemonetics Corp (HAE) reported a robust first quarter for fiscal year 2026, ending June 28, 2025, with revenue reaching $325.5 million, marking a significant 1 -
Haemonetics Corp. Q3 Earnings Show Strong Revenue and Net Income
— Feb 6, 2025 Risk: low
Haemonetics Corp. reported its third-quarter results for the fiscal year ending March 29, 2025, with total revenue of $347 million and net income of $73 million -
Haemonetics Corp. Q2 FY25 Equity Changes Detailed
— Nov 7, 2024 Risk: low
Haemonetics Corp. reported its second quarter results for fiscal year 2025, ending September 28, 2024. The company's financial statements show changes in its eq -
Haemonetics Corp. Files 10-Q for Period Ending December 30, 2023
— Feb 8, 2024 Risk: low
HAEMONETICS CORP (HAE) filed a Quarterly Report (10-Q) with the SEC on February 8, 2024. Haemonetics Corp. filed a 10-Q report for the period ending December 30
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX